AnGes, Inc. - ROE
4563.T
Price:
$36
Market Cap:
$14.24B
AnGes, Inc., a biopharmaceutical firm headquartered in Ibaraki, Japan, and established in 1999, focuses on pioneering the research and development of gene-based medical solutions. Its primary therapeutic asset is Hepatocyte Growth Factor (HGF) Plasmid, an innovative gene therapy designed to address critical limb ischemia, a severe circulatory condition impacting the legs. The company's diverse pipeline also includes NF-kB Decoy Oligonucleotide, a nucleic acid medicine formulated to suppress inflammation for various ailments, including low back pain. Furthermore, AnGes is actively developing treatments for atopic dermatitis and disc degeneration, as well as specialized medical devices aimed a...[Read more]
Industry
Biotechnology
IPO Date
2002-09-25
Stock Exchange
JPX
Ticker
4563.T
PE Ratio
[-3.78]
ROE
[-163.39%]
Current Ratio
[0.95]
Dividend Yield
[0%]
Enterprise Value
[14.68B]
Dividend History
The ROE as of September 2026 (TTM) for AnGes, Inc. (4563.T) is -163.39%
According to AnGes, Inc.’s latest financial reports and current stock price. The company's current ROE is -163.39%. This represents a change of -25.59% compared to the average of -219.56% of the last 4 quarters.
AnGes, Inc. (4563.T) Historical ROE (quarterly & annually)
How has 4563.T ROE performed in the past?
The mean historical ROE of AnGes, Inc. over the last ten years is -189.33%. The current -163.39% ROE has changed -13.70% with respect to the historical average. Over the past ten years (40 quarters), 4563.T's ROE was at its highest in in the September 2023 quarter at 0.11%. The ROE was at its lowest in in the December 2024 quarter at -972.46%.
Average
-189.33%
Median
-43.55%
Minimum
-1304.33%
Maximum
-12.88%
AnGes, Inc. (4563.T) ROE by Quarter and Year
Discovering the peaks and valleys of AnGes, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 4.48%
Maximum Annual ROE = -12.88%
Minimum Annual Increase = -87.23%
Minimum Annual ROE = -1304.33%
| Year | ROE | Change |
|---|---|---|
| 2025 | -166.55% | -87.23% |
| 2024 | -1304.33% | 4.48% |
| 2023 | -28.49% | -41.09% |
| 2022 | -48.36% | 36.63% |
| 2021 | -35.40% | 174.80% |
| 2020 | -12.88% | -58.60% |
| 2019 | -31.11% | -19.69% |
| 2018 | -38.74% | -62.73% |
| 2017 | -103.94% | -15.80% |
| 2016 | -123.45% | 25.78% |
AnGes, Inc. (4563.T) Average ROE
How has 4563.T ROE performed in the past?
The current ROE of AnGes, Inc. (4563.T) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-499.79%
5-year avg
-316.63%
10-year avg
-189.33%
AnGes, Inc. (4563.T) ROE vs. Peers
How is 4563.T’s ROE compared to its peers?
AnGes, Inc.’s ROE is less than CUC Inc. (7.36%), less than Mizuho Medy Co.,Ltd. (17.82%), greater than Renascience Inc. (-12.00%), less than Rion Co., Ltd. (10.14%), less than Koa Shoji Holdings Co.,Ltd. (12.54%), greater than Oncolys BioPharma Inc. (-47.76%), less than Kusurinomadoguchi, Inc. (30.49%), less than WIN-Partners Co., Ltd. (8.96%), greater than Japan Tissue Engineering Co., Ltd. (-8.40%), less than Charm Care Corporation (18.74%),
| Company | ROE | Market cap |
|---|---|---|
| 7.36% | $22.69B | |
| 17.82% | $32.73B | |
| -12.00% | $15.82B | |
| 10.14% | $39.58B | |
| 12.54% | $31.76B | |
| -47.76% | $187.12B | |
| 30.49% | $30.87B | |
| 8.96% | $34.76B | |
| -8.40% | $33.10B | |
| 18.74% | $46.54B |
Build a custom stock screener for AnGes, Inc. (4563.T) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AnGes, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
AnGes, Inc. (4563.T) and other stocks custom spreadsheet templates
The easiest way to analyze a company like AnGes, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is AnGes, Inc.'s ROE?
How is the ROE calculated for AnGes, Inc. (4563.T)?
What is the highest ROE for AnGes, Inc. (4563.T)?
What is the 3-year average ROE for AnGes, Inc. (4563.T)?
What is the 5-year average ROE for AnGes, Inc. (4563.T)?
How does the current ROE for AnGes, Inc. (4563.T) compare to its historical average?